Opsens Receives Grant from NRC-IRAP to Develop New Medical Device

Bookmark and Share

QUEBEC, July 8 /CNW Telbec/ - Opsens Inc. (TSX VENTURE EXCHANGE:OPS - News; “Opsens”) is proud to announce it has been awarded a $498,500 grant from the National Research Council Industrial Research Assistance Program (“NRC-IRAP”).

Opsens will use the financial assistance to develop its own medical product, and will also receive technical advice from the NRC-IRAP. Opsens has already filed a patent application related to the product’s concept, being developed under ISO 13485 quality management system to obtain regulatory approval.

“Opsens is always on the look out for new products and new markets to diversify its sources of revenues and to create value for its shareholders,” said Claude Belleville, Vice-President R&D. “We believe that this innovative product will be an important breakthrough in medical devices.”

Opsens wants to thank the NRC-IRAP for its advice in the planning of this project and for its financial contribution.

About Opsens (www.opsens.com)

Opsens is a leading developer, manufacturer and supplier of a wide range of fiber optic sensors and associated signal conditioners based on proprietary patented and patent pending technologies. Opsens’ sensors provide long-term accuracy and reliability in the harshest environments. Opsens provides sensors to measure pressure, temperature, strain and displacement to original equipment manufacturers (OEM) and end-users in the oil and gas, medical, high-power transformers, and laboratory fields. Opsens provides complete technical support, including installation, training, after-sales service, for its fiber optics systems that are regulated by the ISO 9001-2000 norm.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements contained in this press release involve known and unknown risks, uncertainties and other factors that may cause actual results, performance and achievements of Opsens to be materially different from any future results, performance or achievements expressed or implied by the said forward-looking statements.

For further information

Pierre Carrier, President and CEO, (418) 682-9996 Louis Laflamme, CA, CFO, (418) 682-9996